| Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ... Molecular psychiatry 25 (7), 1592-1603, 2020 | 326 | 2020 |
| Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review MK Jha, A Qamar, M Vaduganathan, DS Charney, JW Murrough Journal of the American College of Cardiology 73 (14), 1827-1845, 2019 | 267 | 2019 |
| An electroencephalographic signature predicts antidepressant response in major depression W Wu, Y Zhang, J Jiang, MV Lucas, GA Fonzo, CE Rolle, C Cooper, ... Nature biotechnology 38 (4), 439-447, 2020 | 207 | 2020 |
| Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial MK Jha, A Minhajuddin, BS Gadad, T Greer, B Grannemann, A Soyombo, ... Psychoneuroendocrinology 78, 105-113, 2017 | 194 | 2017 |
| A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder A Feder, S Costi, SB Rutter, AB Collins, U Govindarajulu, MK Jha, ... American Journal of Psychiatry 178 (2), 193-202, 2021 | 153 | 2021 |
| Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks BS Gadad, MK Jha, A Czysz, JL Furman, TL Mayes, MP Emslie, ... Journal of affective disorders 233, 3-14, 2018 | 153 | 2018 |
| Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study CA Webb, MH Trivedi, ZD Cohen, DG Dillon, JC Fournier, F Goer, M Fava, ... Psychological medicine 49 (7), 1118-1127, 2019 | 127 | 2019 |
| Pharmacological treatments for patients with treatment-resistant depression VL Ruberto, MK Jha, JW Murrough Pharmaceuticals 13 (6), 116, 2020 | 111 | 2020 |
| Effect of intrinsic patterns of functional brain connectivity in moderating antidepressant treatment response in major depression CR Chin Fatt, MK Jha, CM Cooper, G Fonzo, C South, B Grannemann, ... American Journal of Psychiatry 177 (2), 143-154, 2020 | 94 | 2020 |
| Efficacy of esketamine augmentation in major depressive disorder: a meta-analysis GI Papakostas, NC Salloum, RS Hock, MK Jha, JW Murrough, SJ Mathew, ... The Journal of clinical psychiatry 81 (4), 6603, 2020 | 83 | 2020 |
| Personalized antidepressant selection and pathway to novel treatments: clinical utility of targeting inflammation MK Jha, MH Trivedi International journal of molecular sciences 19 (1), 233, 2018 | 79 | 2018 |
| Post adoption depression. ES Fields, JM Meuchel, CJ Jaffe, M Jha, JL Payne Archives of Women's Mental Health 13 (2), 147-151, 2010 | 79* | 2010 |
| Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection MK Jha, A Minhajuddin, BS Gadad, TL Greer, TL Mayes, MH Trivedi Brain, behavior, and immunity 66, 103-110, 2017 | 63 | 2017 |
| Ketamine versus ECT for nonpsychotic treatment-resistant major depression A Anand, SJ Mathew, G Sanacora, JW Murrough, FS Goes, M Altinay, ... New England Journal of Medicine 388 (25), 2315-2325, 2023 | 61 | 2023 |
| When discontinuing SSRI antidepressants is a challenge: management tips MK Jha, AJ Rush, MH Trivedi American Journal of Psychiatry 175 (12), 1176-1184, 2018 | 61 | 2018 |
| Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role? G Scaini, BL Mason, AP Diaz, MK Jha, JC Soares, MH Trivedi, J Quevedo Molecular psychiatry 27 (2), 1095-1102, 2022 | 59 | 2022 |
| Improvements in psychosocial functioning and health‐related quality of life following exercise augmentation in patients with treatment response but nonremitted major depressive … TL Greer, JM Trombello, CD Rethorst, TJ Carmody, MK Jha, A Liao, ... Depression and anxiety 33 (9), 870-881, 2016 | 56 | 2016 |
| Cortical connectivity moderators of antidepressant vs placebo treatment response in major depressive disorder: secondary analysis of a randomized clinical trial CE Rolle, GA Fonzo, W Wu, R Toll, MK Jha, C Cooper, C Chin-Fatt, ... JAMA psychiatry 77 (4), 397-408, 2020 | 54 | 2020 |
| A structured approach to detecting and treating depression in primary care: VitalSign6 project MK Jha, BD Grannemann, JM Trombello, EW Clark, SL Eidelman, ... The Annals of Family Medicine 17 (4), 326-335, 2019 | 53 | 2019 |
| Early improvement in work productivity predicts future clinical course in depressed outpatients: findings from the CO-MED trial MK Jha, A Minhajuddin, TL Greer, T Carmody, AJ Rush, MH Trivedi American Journal of Psychiatry 173 (12), 1196-1204, 2016 | 50 | 2016 |
Madhukar TrivediUT Southwestern Medical SchoolVerified email at utsouthwestern.edu
